BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21513767)

  • 1. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
    Pan B; Huang XF; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
    Deng C; Pan B; Engel M; Huang XF
    Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.
    Deng C; Pan B; Hu CH; Han M; Huang XF
    Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons.
    Allison JG; Das PM; Ma J; Inglis FM; Jones FE
    Neurosci Res; 2011 Jun; 70(2):155-63. PubMed ID: 21352860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.
    Geddes AE; Huang XF; Newell KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):896-904. PubMed ID: 21371516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
    du Bois TM; Newell KA; Huang XF
    Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
    Newell KA; Karl T; Huang XF
    Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: more evidence for less glutamate.
    Morrison PD; Pilowsky LS
    Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
    Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
    J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.
    Dang R; Guo Y; Cai H; Yang R; Liang D; Lv C; Jiang P
    J Toxicol Sci; 2016 Apr; 41(2):303-9. PubMed ID: 26961615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses.
    Hou XJ; Ni KM; Yang JM; Li XM
    Neuroscience; 2014 Mar; 261():107-17. PubMed ID: 24374327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of neuregulin-1 (nrg1) and erbB4 transcripts in embryonic chick hindbrain.
    Dixon M; Lumsden A
    Mol Cell Neurosci; 1999 Apr; 13(4):237-58. PubMed ID: 10328884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.
    O'Tuathaigh CMP; Mathur N; O'Callaghan MJ; MacIntyre L; Harvey R; Lai D; Waddington JL; Pickard BS; Watson DG; Moran PM
    Schizophr Bull; 2017 Sep; 43(5):1100-1113. PubMed ID: 28338897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia.
    Barakat A; Dean B; Scarr E; Evin G
    Schizophr Res; 2010 Dec; 124(1-3):200-7. PubMed ID: 20926259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain.
    Wood JD; Bonath F; Kumar S; Ross CA; Cunliffe VT
    Hum Mol Genet; 2009 Feb; 18(3):391-404. PubMed ID: 18996920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model.
    Li C; Tang Y; Yang J; Zhang X; Liu Y; Tang A
    Neurochem Res; 2016 Aug; 41(8):2049-64. PubMed ID: 27097547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.
    Harrison PJ; Law AJ
    Biol Psychiatry; 2006 Jul; 60(2):132-40. PubMed ID: 16442083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
    Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
    J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene models of schizophrenia: DISC1 mouse models.
    Jaaro-Peled H
    Prog Brain Res; 2009; 179():75-86. PubMed ID: 20302820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.